Brain Tumor Treatments: Less-Toxic
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Less-Toxic
Please scroll down past the trials to see pages on this site about this topic!

The term Less Toxic includes targeted treatments. While they may be less toxic than the older chemotherapies, they may still have significant toxicities and side effects.

  Showing Treatment 1 to 25 of 187 Next 25 Location Last Updated
Details Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) Memphis, TN USA 01/14/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Houston, TX USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Baltimore, MD USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Denver, CO USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Rochester, NY USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma New York, NY USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Washington, DC USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Chicago, IL USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Toronto, Ontario, , CANADA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Gainesville, FL USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma New York, NY USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Nashville, TN USA 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Calgary, Alberta, Canada 01/03/2010
Details Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Tel-Hashomer, Israel 01/03/2010
Details A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma Philadelphia, PA USA 12/30/2009
Details Randomized, factorial-design, Phase II trial of Temozolomide alone and in combination with possible permutations of Thalidomide, Isotretinoin and/or Celecoxib as post-radiation adjuvant therapy of glioblastoma Houston, TX USA 12/03/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Pittsburgh, PA USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Dallas, TX USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) New York, NY USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Edison, NJ USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Orlando, FL USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Chicago, IL 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Scarborough, ME USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Danville, PA USA 11/30/2009
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Graz, Austria 11/30/2009

(Relevance) Page Title - click title to go to the page!

  (0.8510)   Brain Tumor Treatments: Less-Toxic
  (0.7967)   Brain Tumor Treatments: Canada
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Emerging Med Trials Matcher
  (0.7967)   Brain Tumor Treatments: Israel
  (0.7967)   Brain Tumor Treatments: New York
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Brain Tumor Treatments: Washington
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error
  (0.7742)   Website Error




Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites